• Nomura Investment Forum 2015. Video

What's New

  • Show All
2016/12/08
Notice of Completion of Acquisition of Own Shares (Acquisition of own shares pursuant to the provision of Article 165, Paragraph 2 of the Companies Act)
2016/12/05
Notice Regarding the Status (Progress Report) of Acquisition of Own Shares (Acquisition of own shares pursuant to the provision of Article 165, Paragraph 2 of the Companies Act)
2016/12/01
Secondary Endpoint Data for S-033188, a Novel Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza, Support Favorable Primary Endpoint Data Previously Released - Oral Presentation Presented at APCCMI -
2016/11/28
The Decision of Patent Revocation and Patent Infringement Actions against MSD in United Kingdom Concerning HIV Integrase Inhibitors
2016/11/24
License agreement with Tokushima University on the novel type A2 Botulinum toxin candidate for the post-stroke spasticity treatment
2016/11/08
Audio webcasting: First Half of FY2016 Financial Results and Updates to Shionogi Growth Strategy (SGS2020)
2016/11/08
Notification of Results of Share Repurchase Through the Off-auction Own Share Repurchase Transaction (ToSTNeT-3) System
2016/11/07
Notification Regarding Share Repurchase Through the Off-auction Own Share Repurchase Transaction (ToSTNeT-3) System
2016/11/02
Shionogi Launched Pirespa® 200mg Tablet for Idiopathic Pulmonary Fibrosis Treatment In Taiwan (比樂舒活錠200 毫克®)
2016/11/02
Shionogi Launched Rapiacta® 300mg Bag for Intravenous Drip Infusion In Taiwan (瑞貝塔®點滴靜脈注射液300毫克)
2016/10/31
Notice Regarding Acquisition of Own Shares and Cancellation of Treasury Shares
2016/10/31
Updates to Shionogi Growth Strategy (SGS2020)
2016/10/31
Financial Results for the Second Quarter of FY2016